PMS38 ECONOMIC ANALYSIS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP OR KNEE REPLACEMENT IN SPAIN

Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)75177-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)75177-9/fulltext
Section Title :
Section Order : 1104
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75177-9&doi=10.1016/S1098-3015(10)75177-9
HEOR Topics :
Tags :
Regions :